Hong Kong IT Stock News

Shanghai Forest Cabin Cosmetics Group walked into this earnings day with a strong recent share run, including a double digit 30 day gain, yet the stock closed at HK$59.1 as investors weighed what the new numbers really mean. The headline is clear for a beauty stock: revenue for the first half of 2026 came in at C¥1,499.7m and basic earnings per share reached C¥1.81, while trailing net profit margin sat at 15%. The story now is whether this profit profile matches the growth reputation that has...

Sunshine Lake Pharma stock has been drifting lower in recent weeks, and today's earnings story is really about valuation nerves finally catching up with fragile profits. The company remains loss making over the last 12 months, while the stock trades on a rich price to sales multiple of 6.4x versus much lower sector averages. That gap appears larger when compared with an internal discounted cash flow estimate of HK$5.06 per share against a HK$37.72 market price. The market reaction now depends...

Bairong AI stock closed at HK$5.435 today after the market had a full day to process its H1 2026 earnings. The short term picture is blunt. The company swung from profit last year to a net loss of ¥320.2 million and basic earnings per share of a ¥0.72 loss. Yet the bigger story for you as an investor sits in the multi year expectations around a potential return to profitability and the current P/S of 0.9x, which keeps the valuation debate very much alive. If you are interested in Bairong AI’s...

United Energy Group stock closed at HK$0.405 on 1 September, quietly reflecting a value story that looks inexpensive on trailing numbers, while the underlying earnings picture is more complicated. The headline from this half year is margin pressure. Net profit margin over the last 12 months was 6.1%, lower than the 7.5% level a year earlier, and the period also carried a one off loss of HK$728.4m that weighs on reported profitability. That mix of thinner margins and distorted earnings now...

Guanze Medical Information Industry (Holding) came into this earnings print with a high bar, trading on a P/S of 22.9x in a healthcare sector where peers sit much lower and the stock down 42.1% over three months. The latest H1 2026 numbers land hard against that premium. Revenue for the half year was C¥28.432m while the company reported a basic loss per share of C¥0.41 and a net loss of C¥38.804m. For a stock priced richly against sales, the widening loss profile is the headline that...

North Mining Shares closed at HK$0.052 today after a choppy few months in which the stock fell about 12% over the past week and roughly 24% over three months. On the surface, the latest half year did not look exciting, with first half 2026 revenue of HK$472.5m and basic earnings per share of HK$0.004326. The longer-term picture is more notable. Over the last twelve months the miner reported net income of about HK$222.9m and the shares trade on a trailing P/E of 3.5x, which is below Hong Kong...

Goodbaby International Holdings walked into these results with the stock at HK$1.09 and up roughly 20% to 22% over the past week and month, yet still trading on a P/E of 4.7x and well below some fair value models. The headline from this earnings release is profit power. First half 2026 net income reached HK$275.2m on revenue of HK$4,551.0m and trailing net profit margin is now 4.4%, compared with 3.1% a year earlier. For a consumer products group that lives and dies on operational efficiency,...

Evergrande Property Services Group traded into these results with a stock that has drifted over the past quarter and sits at HK$1.145 after a flat near term run. The market is still fixated on the court ordered liquidation of the majority shareholder and on balance sheet risk, even as the business reports steady profit generation. The headline for today is earnings resilience in the shadow of that strain. Half year net income of C¥517.0m and basic earnings per share of C¥0.05 indicate the...

China Travel International Investment Hong Kong closed at HK$1.145 on Tuesday, barely moved over the past week and soft over the past month. The market reaction looks muted. The headline in these half year results is a clean return to profit. Basic earnings per share for H1 2026 came in at HK$0.0202 and net income reached HK$112.046 million, after a loss in the same period last year. For short term traders, that may not feel exciting. For longer term investors, a tourism operator that has...

Guangdong Investment (SEHK:270) drew fresh attention on 28 August 2026 after reporting higher half year revenue and net income, and announcing an interim dividend of HK$0.2919 per share for the period. Guangdong Investment’s recent earnings and dividend announcement comes after a strong share price run, with a year-to-date share price return of 28.8% and a 1-year total shareholder return of 30.04%, while the 3-year total shareholder return of 74.66% points to longer-term momentum...

Baiwang went into this earnings print on a tear, with the stock up about 33% over the past three months. The latest H1 2026 numbers underline why the valuation already looks full. The company remains loss making, with basic earnings per share of C¥0.19 in the half and trailing 12 month net income still in the red. The key issue is not revenue for Baiwang. It is the strain between continued losses and a P/S of 4.3x, which sits well above Hong Kong information technology peers. That gap between...

New Gonow Recreational Vehicles stock has been on a tear over the past three months, yet today’s H1 2026 earnings remind you why the ride is getting bumpier. Revenue came in at CN¥472.982m while net income from core operations was just CN¥6.609m, leaving very thin profit for each unit sold. The real story sits beyond today’s print. Over the past year, net profit margin has compressed to 0.7% from 4% and the stock still changes hands at about 8.5x sales, far above Asian auto peers. That...

Luye Pharma Group stock has been under pressure, down about 12% over the past week even before traders absorbed the latest half year numbers. That short term weakness sits against a very different story in the earnings line, where trailing twelve month earnings rose much faster than sales and the reported net profit margin reached 11.4%. The main point from this earnings release is profit quality. Luye Pharma Group is now earning more on each yuan of revenue than it did in the prior year, and...

China CITIC Financial Asset Management came into these results looking like a value play, with the stock at HK$0.635 and a P/E around 4x that sat well below Hong Kong capital markets peers. The headline this half is not the share price; it is the earnings power that continues to hold up despite a messy revenue picture and a large one off loss still hanging over the trailing 12 months. Basic earnings per share of CN¥0.075 for the first half and trailing 12 month net income of about CN¥10.9b...

China Development Bank Financial Leasing shares closed at HK$1.51 after the market had a full day to process fresh half year numbers. The stock has drifted only modestly over the past week and month, even as the new report puts the spotlight on one issue. The key point is the valuation gap, which now contrasts with improving profitability. Net income from continuing operations over the trailing twelve months sits at CNY 5,537.2m with a P/E around 3x, while the dividend yield is high and...

China Resources Land stock has been grinding lower for months, yet the latest half year numbers present a very different story on valuation. At HK$28.98 after the post earnings session on 1 September 2026, investors are looking at a P/E of 7.6x while peers sit much higher and a discounted cash flow estimate points to a far richer value. The headline this time is not the CNY 9,841.696m in half year profit on CNY 67,869.309m of revenue. The real tension is between a cheap share price and a...

Investors came into these Easou Technology Holdings results already nursing short term losses, with the stock down over the past week and month, and trading on a rich P/E of 27.6x against lower media sector averages. The headline from this half year is not revenue, which sits at ¥412.4m, but the sharp squeeze in profitability, with net income at only ¥4.4m and basic earnings per share at ¥0.0099. For a stock priced well above peers, that profit compression is a key factor for the market in...

Investors in Z Fin walked into this earnings release with bruises and big hopes. The stock has slid over the past week and month after a volatile run, yet it still trades at a steep discount to one analyst’s estimated value. Today’s H1 2026 numbers hand the market a simple headline: revenue sits at HK$451.6m while the company again reported a sizeable loss, with basic earnings per share of HK$0.45 in the red. The real question now is whether the sharp loss reduction story is enough to justify...

United Laboratories International Holdings stock has sagged over the past month, yet the latest H1 2026 report throws investors a very different challenge. The headline is not revenue; it is profit compression. Trailing net profit margin sits at 4.5% compared with 21.7% last year, while basic earnings per share for the latest half year are a modest ¥0.1762 on revenue of ¥6,165.9m. The market now has to decide whether this sharp squeeze in profitability is a temporary reset or a meaningful...

Victory Securities (Holdings) closed at HK$4.32 after the market digested a mixed H1 2026, with the stock roughly flat over the past week and slightly down over the past month. The headline is not the top line. Revenue for the half year came in at HK$91.3m, while the company reported a loss of HK$7.3m and a basic loss per share of HK$0.0371. The focus for investors is the pressure on profitability. Trailing net profit margin stands at 6.8%, while the stock trades on a P/E of 78x, which is far...

Zall Smart Commerce Group stock closed at HK$0.072 on 1 September, leaving investors to weigh a modest recent rebound against a far tougher earnings reality. The headline in this trade distributor’s half year numbers is a sharp profit squeeze. Management reported H1 2026 revenue of ¥36,905.096m but a net loss of ¥1,149.249m, which flipped basic earnings per share into a loss. Short term traders may focus on the recent 7 day and 30 day gains. Longer term holders are now forced to ask how a...

Shanghai HeartCare Medical Technology stock came into today slightly bruised, down about 5% over the past week and flat over the past month. The immediate question for investors is whether the latest half year numbers justify that caution or start to challenge it. The headline this time is earnings power. Basic earnings per share for the first half of 2026 printed at CN¥1.61 on revenue of CN¥291.0m, while trailing net profit over the last 12 months sits on an 18.1% margin and includes a...

Acotec Scientific Holdings dropped to HK$6.32 at the close on 1 September, extending a tough three months for the stock. Yet the real jolt for investors came from the earnings line. H1 2026 flipped from profit to a net loss of C¥80.8 million, with basic earnings per share sliding into a C¥0.27 loss. For a medical equipment maker that has been priced on strong growth forecasts and a discounted valuation, that profit squeeze is now the headline question. The rest of this earnings story is about...

Angelalign Technology walked into this earnings release with the stock already up strongly over the last quarter, and the market clearly primed for good news. The headline is simple. Revenue for H1 2026 reached US$230.7m and basic earnings per share came in at US$0.16, both aligned with a business that has been rebuilding profitability. The sentiment reckoning sits in valuation. With earnings over the past year supporting a trailing P/E near 51x and a dividend yield that free cash flow does...